Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	80.98	102.32	135.82	135.03	52.07	61.03
Short-Term Investments	244.57	272.33	252.44	331.83	380.74	306.71
Cash & Short-Term Investments	325.55	374.64	388.26	466.86	432.81	367.74
Cash Growth	-16.02%	-3.51%	-16.84%	7.87%	17.70%	17.82%
Receivables	44.99	47.1	34.16	33.51	32.47	30.04
Inventory	2.17	1.73	1.36	1.19	1.03	1.28
Prepaid Expenses	22.21	15.42	9.17	6.23	12	10.03
Restricted Cash	-	-	-	-	-	0.06
Other Current Assets	-	-	-	11.5	-	-
Total Current Assets	394.92	438.89	432.95	519.29	478.3	409.15
Property, Plant & Equipment	12.47	12.68	9.14	10.97	12.39	14.6
Other Intangible Assets	110.59	114.1	121.37	18.57	20.08	21.56
Long-Term Deferred Tax Assets	97.14	81.44	75	74.04	74.88	81.52
Other Long-Term Assets	9.62	9.1	9.99	11.38	8.15	6.64
Total Assets	624.75	656.2	648.44	634.25	593.79	533.46
Accounts Payable	2.18	3.5	7.15	12.69	0.93	1.05
Accrued Expenses	50.26	31.32	28.92	30.53	31.2	27.99
Current Portion of Leases	4.68	4.27	2.4	2.33	2.31	2.12
Other Current Liabilities	64.37	60.9	49.24	45.89	39.98	34.78
Total Current Liabilities	121.49	99.98	87.7	91.44	74.42	65.94
Long-Term Leases	6.96	8.09	7.01	8.81	10.06	11.5
Other Long-Term Liabilities	9.97	9.59	8.83	6.8	4.39	2.76
Total Liabilities	138.42	117.66	103.53	107.05	88.86	80.19
Common Stock	0.06	0.06	0.06	0.06	0.06	0.06
Additional Paid-In Capital	716.87	712.71	700.27	686.24	669.22	650.3
Retained Earnings	-230.99	-174.29	-155.39	-157.9	-164.18	-197.33
Comprehensive Income & Other	0.4	0.07	-0.03	-1.19	-0.18	0.24
Shareholders' Equity	486.33	538.55	544.91	527.2	504.93	453.27
Total Liabilities & Equity	624.75	656.2	648.44	634.25	593.79	533.46
Total Debt	11.64	12.36	9.4	11.14	12.37	13.61
Net Cash (Debt)	313.91	362.28	378.86	455.72	420.45	354.13
Net Cash Growth	-17.23%	-4.38%	-16.86%	8.39%	18.73%	19.02%
Net Cash Per Share	5.36	6.23	6.58	8.00	7.39	6.42
Filing Date Shares Outstanding	59.09	58.32	57.54	56.79	55.91	54.88
Total Common Shares Outstanding	59.08	58.31	57.53	56.78	55.9	54.87
Working Capital	273.43	338.91	345.25	427.86	403.88	343.21
Book Value Per Share	8.23	9.24	9.47	9.28	9.03	8.26
Tangible Book Value	375.74	424.45	423.54	508.63	484.85	431.71
Tangible Book Value Per Share	6.36	7.28	7.36	8.96	8.67	7.87
Machinery	-	8.23	7.78	7.58	7.03	6.71
Leasehold Improvements	-	5.47	5.44	5.42	5.46	5.46

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q